First Quarter 2018 Investor Presentation
Investor Presentation
First three months of 2018
Slide 37
Poor diagnosis rates, lack of access to optimal treatment
and poor glycaemic control remain global problems
Diagnosis and optimal treatment
remains a challenge – the rule of halves
-
The worldwide challenge of glycaemic control:
Mean HbA1c in type 2 diabetes
All people with
diabetes
changing
diabetes
50% are diagnosed
100%
50%
25%
50% have access to
care
12%
50% get decent
care
50% reach target
Canada
US
Latin America
7.3%¹
7.2%²
7.6%³
China 7.2-9.5%4
India 7.3-9.3%4
Japan
7.3-7.7%5
Korea
7.9-8.7%6
Russia
7.2-9.5%4
Germany
Greece
6.7-9.2%7
7.1-9.7%7,8,4
Italy
7.7-8.3%4
Poland
7.3-8.9%4
Portugal
7.9-9.7%7
Romania
7.9-9.9%7
Spain
7.6-9.2%8
Sweden
7.4-8.7%7
Turkey
UK
7.6-10.6%7
7.4-8.7%⁹
1 Harris et al. Diabetes Res Clin Pract 2005;70:90-7; 2 Hoerger et.al. Diabetes Care
2008;31:81-6; 3 Lopez Stewart et al. Rev Panam Salud Publica 2007;22:12-20;
4 Valensi et al. Int J Clin Pract 2009;63(3):522-31; 5 Arai et al. J Diabetes Investig. 2012
Aug 20;3(4):396-401; 6 Ko et al. Diab Med 2007;24:55-62; 7 Oguz et al. Curr Med Res
Opin 2013;29:911-20; 8 Liebl et al. Diab Ther 2012;3:e1-10; 9 Blak et al. Diab Med
2012;29:e13-20
novo nordiskView entire presentation